SCHEMBL17034992

SCHEMBL17034992

c1ccc(-c2nc3ccccc3c3c2cc(-c2c4ccccc4c(-c4cccc5c4oc4ccccc45)c4ccccc24)c2ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
CSF1R P07333 1/20 0.38
PDGFRB P09619 1/20 0.38
KIT P10721 1/20 0.38
FLT3 P36888 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GGPS1 O95749 1/20 0.36
PRKDC P78527 4/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.34
ADORA2A P29274 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
NUDT1 P36639 1/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035091 0.92 ALOX5 (0.40) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL17034995 0.89 ALOX5 (0.48) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL17034994 0.89 ALOX5 (0.48) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL18842541 0.89 MAPT (0.36) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL19009728 0.86 ALOX5 (0.40) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL18907187 0.86 ALOX5 (0.38) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL18842530 0.86 MAPT (0.34) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL20864381 0.86 ALOX5 (0.44) ALOX5MAPTMEN1CSF1RPDGFRB
SCHEMBL17034991 0.84 CHEK2 (0.35) MAPTMEN1CSF1RPDGFRBKIT
SCHEMBL18842627 0.83 ALOX5 (0.42) ALOX5MAPTMEN1CSF1RPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 2058/4885MAPT 1406/4885MEN1 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.